Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. | 138,000 | reported | 29 May 2025 | tx 11+2,564,667 |
| WIRELESS HOLDINGS INC | 64,682 | reported | 07 May 2010 | tx 30+1,503,935−57,922 |
| Sucampo Pharmaceuticals, Inc. | 45,764 | reported | 16 Dec 2014 | tx 39+234,048−168,240 |
| CYTRX CORP | 5,000 | reported | 15 Jan 2024 | tx 1+5,000 |
| OSIRIS THERAPEUTICS, INC. | 0 | reported | 23 Nov 2007 | tx 6+125,000−35,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2025 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 138,000 | 0.00 USD | deriv |
| 05 Dec 2024 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 350,000 | 0.00 USD | deriv |
| 25 Mar 2024 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 60,000 | 0.00 USD | deriv |
| 15 Jan 2024 | GRANT_AWARD | CYTRX CORP | 5,000 | 0.00 USD | deriv |
| 23 May 2023 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 420,000 | 0.00 USD | |
| 23 May 2023 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 300,000 | 0.00 USD | deriv |
| 20 Sept 2022 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 75,000 | 0.42 USD | |
| 19 Sept 2022 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 25,000 | 0.43 USD | |
| 18 Aug 2022 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 1,000,000 | 0.00 USD | |
| 23 Feb 2022 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 6,667 | 0.00 USD | deriv |
| 07 Dec 2021 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 130,000 | 0.00 USD | deriv |
| 02 Nov 2021 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 60,000 | 0.00 USD | deriv |
| 16 Dec 2014 | SALE | Sucampo Pharmaceuticals, Inc. | 42,900 | 12.91 USD | |
| 16 Dec 2014 | EXERCISE | Sucampo Pharmaceuticals, Inc. | 42,900 | 4.07 USD | |
| 15 Dec 2014 | SALE | Sucampo Pharmaceuticals, Inc. | 7,100 | 12.89 USD | |
| 15 Dec 2014 | EXERCISE | Sucampo Pharmaceuticals, Inc. | 7,100 | 4.07 USD | |
| 16 Dec 2014 | EXERCISE | Sucampo Pharmaceuticals, Inc. | 42,900 | 0.00 USD | deriv |
| 15 Dec 2014 | EXERCISE | Sucampo Pharmaceuticals, Inc. | 7,100 | 0.00 USD | deriv |
| 11 Sept 2014 | GRANT_AWARD | Sucampo Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 11 Sept 2014 | GRANT_AWARD | Sucampo Pharmaceuticals, Inc. | 22,027 | 0.00 USD | deriv |
| 31 Mar 2014 | GRANT_AWARD | Sucampo Pharmaceuticals, Inc. | 220 | 6.79 USD | |
| 30 Jun 2014 | GRANT_AWARD | Sucampo Pharmaceuticals, Inc. | 267 | 6.56 USD | |
| 27 Feb 2014 | EXERCISE | Sucampo Pharmaceuticals, Inc. | 2,500 | 4.07 USD | |
| 27 Feb 2014 | SALE | Sucampo Pharmaceuticals, Inc. | 2,390 | 9.00 USD | |
| 27 Feb 2014 | SALE | Sucampo Pharmaceuticals, Inc. | 110 | 9.06 USD |
1 purchase reported after at least 12 months of silence — most recent on 18 Dec 2009.